期刊文献+

帕利哌酮治疗流浪精神分裂症患儿阴性症状的效果 被引量:2

Street Children's Clinical Features with Schizophrenia and Clinical Curative Effects to Children by Paliperidone
原文传递
导出
摘要 目的观察帕利哌酮治疗流浪精神分裂症患儿阴性症状的疗效。方法选择我院收治的流浪精神分裂症儿童28例作为研究对象,治疗开始时对患儿的各种阴性症状进行阴性症状评定量表(SANS)评估后使用帕利哌酮进行治疗,疗程6个月,并在治疗各阶段对临床疗效进行评定对比。结果入组时流浪精神分裂症儿童在SANS 5项因子(思维贫乏;情感平淡或迟钝;意志缺乏/情感淡漠;兴趣缺乏/社交缺乏,注意损害)均处于高分值水平(12.3±1.1,10.4±1.6,14.7±1.0,9.4±1.2,11.8±1.5);经帕利哌酮治疗后患儿各项阴性症状逐渐缓解,治疗结束时5项因子分值与治疗初比较有显著改善(t=29.25,15.66,22.61,17.54,24.57;P<0.01)。结论帕利哌酮能显著改善流浪精神分裂症儿童各种严重的阴性症状。 Objective To observe effects of paliperidone on treatment to street children 's negative symptoms with schizophrenia . Methods 28 street children with schizophrenia were selected as research object .Patients'negative symptoms were evaluated by SANS at the beginning and treated by Paliperidone for 6 months.Clinical curative effects were contrasted at each stages .Results The children's five components(thought poverty;emotional insipid or dull;will lack /emotional indifference;interest/social lack;pay attention damage) of SANS were all in high score level (12.3 ±1.1;10.4 ±1.6;14.7 ±1.0;9.4 ±1.2;11.8 ±1.5);Each negative symptoms had gradual-ly eased after treated by paliperidone .The scores of five components had significantly improved at end of treatment compared with the be -ginning(t=29.25,15.66,22.61,17.54,24.57;P〈0.01).Conclusion It can significantly improve street children's negative symp-toms with schizophrenia by paliperidone .
出处 《中国健康心理学杂志》 2014年第9期1306-1307,共2页 China Journal of Health Psychology
关键词 帕利哌酮 流浪精神分裂症儿童 阴性症状 精神病学 Paliperidone Street children with schizophrenia Negative symptom Psychiatry
  • 相关文献

参考文献15

  • 1埃里克·J·马什.异常儿童心理[M].3版.上海:上海人民出版社.2009:388-389.
  • 2潘多,李泽爱,刘寰忠.儿童精神分裂症预后影响因素研究进展[J].精神医学杂志,2010,23(1):65-67. 被引量:15
  • 3司天梅,杨建中,舒良,王希林,孔庆梅,周沫,李雪霓,刘粹.阳性和阴性症状量表(PANSS,中文版)的信、效度研究[J].中国心理卫生杂志,2004,18(1):45-47. 被引量:902
  • 4范肖冬译.ICD-10精神与行为障碍分类[M].北京:人民卫生出版社,1993.19-20
  • 5李转清,陈全花,郑龙娃,冯砚国.心理干预对儿童精神分裂症患者亲属心理健康的影响[J].健康心理学杂志,2003,11(2):148-149. 被引量:1
  • 6杨铭哲,林昭宇,梁云海,吴逢春,蒲绮霞,蓝晓嫦.帕利哌酮缓释片治疗精神分裂症的疗效与安全性[J].中国健康心理学杂志,2013,21(5):646-648. 被引量:5
  • 7Kramer M, Simpson G, Maciulis V, et al. Paliperidone extended - re- lease tablets for prevention of symptom recurrence in patients with schizophrenia : A randomized, double - blind, placebo - controlled study [ J ]. J Clin Psychopharmacology ,2007,27 ( 1 ) :6-14.
  • 8Fowler J A, Bettinger T L, Argo T R. Paliperidone extended - release tablets for the acute and maintenance treatment of schizophrenia [ J ]. Clin Therapeutics ,2008,30 (2) :231-248.
  • 9Canuso C M, Dirks B, Carothers J, et al. Randomized, double - blind. pl aeebo - controlled study of paliperidone extended - release and quetiapine ininpatients with recently exacerbated schizophrenia [ J ]. Am J Psychiatry,2009,166 (6) :691-701.
  • 10Tzimos A, Samokhvalov V, Kramer M, et al. Safety and tolerability of oral paliperidone extended - release tablets in elderly patients with schizophrenia : A double - blind, placebo - controlled study with six - month open - label extension[ J]. Am J Geriatric Psychiatry,2008,16 (1) :31-43.

二级参考文献53

  • 1朱培俊,陈志恩,朱培林,张静,吴素琴,戴小玲.儿童精神分裂症患者的预后及相关因素分析[J].中华精神科杂志,2006,39(3):137-140. 被引量:11
  • 2王莹,李刚,李涛,邹宏涛.青少年精神分裂症患者家庭因素的研究[J].临床精神医学杂志,2007,17(3):168-170. 被引量:16
  • 3Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition[J]. Am J Psychiatry, 2004, 161 (2) : 1 -56.
  • 4Canadian Psychiatric Association. Clinical practice guidelines: treatment of schizophrenia [ J]. Can J Psychiatry, 2005, 50 (1):7-57.
  • 5Grant S, Fitton A. Risperidone: a review of its pharmacology and therapeutic potential in the treatment of schizophrenia[ J ]. Drags, 1994, 48(2) : 253 -273.
  • 6Revill P, Serradell N, Bolos J. Paliperidone: antipsychotie agent treatment of bipolar disorder dual dopamine D2/5 - HT2A receptor antagonist[ J ]. Drugs Future, 2006, 31 (7) : 579 - 584.
  • 7Herbert YM, William VB, Isaax FN, et al. Efficacy and tolerability of oral paliperidone extended- release tablets in the treatment of acute schizophrenia: pooled data from three 6 - week, placebo- controlled studies [ J]. J Clin Psychiatry, 2008, 69(5) : 817 -829.
  • 8Tzimos A, Lramer M, Ford L, et al. A six - week placebo - controlled study on the safety and tolerability of flexible doses of oral paliperidone extended - release tablets in the treatment of schizophrenia in elderly patients [ C ]. 159^th Annual Meeting of the American Psychiatry Association, 2006, 183.
  • 9Kane J, Canas F, Kramer M, et al. Treatment of schizophrenia with paliperidone extended - release tablets : a 6 - week placebo - controlled trial[ J]. Schizophrenia Research, 2007, 90( 1 ) : 147 - 161.
  • 10Lehman AF, Buchanan RW, Dickerson FB, et al. Evidence - based treatment for schizophrenia [ J ]. Psyehiatr Clin North Am, 2003, 26. 939- 954.

共引文献1024

同被引文献20

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部